Cardiology Surgical & Interventional Cardiology Devices Market – Cardiac Surgery, Cardiac Rhythm Management, valvular heart disease, Vascular Closure, Cardiac Surgery, CABG, Market Research, cardiology medical devices, Market Size, Market Share, Global Trends & Competitive Analysis, Forecast 2014-2021

Date: 2015-10

“The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached – there is 3-5% probability of patient鈥檚 death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment.
US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.
Key companies profiled include
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging) ,
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample